This grant is for Small Business Concerns (SBCs), offering Small Business Innovative Research (SBIR) Phase I, II, Direct to Phase II, and Fast Track awards. Its purpose is to foster the development of novel resources, methods, and New Approach Methodologies (NAMs) for developmental neurotoxicity (DNT) testing. This initiative aims to enhance understanding of environmental chemicals’ contribution to neurodevelopmental disorders by addressing current challenges and gaps in DNT assessment. The supported screening systems and technologies are expected to yield cost-effective, quicker, and comprehensive results, significantly improving our insights into the role of environmental chemicals in DNT. This funding prioritizes innovative solutions for a critical public health issue.
Opportunity ID: 347009
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-ES-23-008 |
| Funding Opportunity Title: | Novel Approaches for Developmental Neurotoxicity Testing (R43/R44 Clinical Trial Not Allowed) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Environment Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.113 — Environmental Health |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Mar 21, 2023 |
| Last Updated Date: | Mar 21, 2023 |
| Original Closing Date for Applications: | Jul 07, 2023 |
| Current Closing Date for Applications: | Jul 07, 2023 |
| Archive Date: | Aug 12, 2023 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | $295,924 |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Small businesses |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, may be allowed. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | This Notice of Funding Opportunity (NOFO) supports Phase I (R43), Phase II (R44), Direct to Phase II (R44), and Fast Track (R44) Small Business Innovative Research (SBIR) grant applications from small businesses concerns (SBCs) to develop resources, new methods, and approaches that can be applied in testing strategies to help understand the role of environmental chemicals in the etiology of the neurodevelopmental disorders. There is a need for novel and innovative approaches including New Approach Methodologies (NAMs) that can provide effective ways to address current challenges and gaps in the assessment of Developmental Neurotoxicity (DNT). These screening systems or technologies, when fully developed and validated with appropriate throughput and controls, are expected to provide cost-effective, quicker and/or comprehensive results to understand the underlying role of environmental chemicals in the DNT. |
| Link to Additional Information: | https://grants.nih.gov/grants/guide/rfa-files/RFA-ES-23-008.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH Grants Information
grantsinfo@nih.gov Email:grantsinfo@nih.gov |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
Folder 347009 Full Announcement-RFA-ES-23-008 -> RFA-ES-23-008-Full-Announcement.pdf
Packages
| Agency Contact Information: | NIH Grants Information grantsinfo@nih.gov Email: grantsinfo@nih.gov |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| FORMS-H | Use for due dates on or after January 25, 2023 | PKG00280707 | Jun 07, 2023 | Jul 07, 2023 | View |
Package 1
Mandatory forms
347009 RR_SF424_5_0-5.0.pdf
347009 PHS398_CoverPageSupplement_5_0-5.0.pdf
347009 RR_OtherProjectInfo_1_4-1.4.pdf
347009 PerformanceSite_4_0-4.0.pdf
347009 RR_KeyPersonExpanded_4_0-4.0.pdf
347009 RR_Budget_3_0-3.0.pdf
347009 PHS398_ResearchPlan_5_0-5.0.pdf
347009 SBIR_STTR_Information_3_0-3.0.pdf
347009 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
347009 RR_SubawardBudget30_3_0-3.0.pdf
347009 PHS_AssignmentRequestForm_3_0-3.0.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
